LV14230A - Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai - Google Patents

Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai

Info

Publication number
LV14230A
LV14230A LVP-09-86A LV090086A LV14230A LV 14230 A LV14230 A LV 14230A LV 090086 A LV090086 A LV 090086A LV 14230 A LV14230 A LV 14230A
Authority
LV
Latvia
Prior art keywords
parkinson
disease
prevention
treatment
pharmaceutical composition
Prior art date
Application number
LVP-09-86A
Other languages
English (en)
Other versions
LV14230B (lv
Inventor
Vija Kluša
Jolanta Pupure
Sergejs Isajevs
Juris Rumaks
Šimons Svirskis
Inga Šaicāne
Ivars KALVIŅŠ
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-09-86A priority Critical patent/LV14230B/lv
Priority to PCT/EP2010/002658 priority patent/WO2010124873A1/en
Publication of LV14230A publication Critical patent/LV14230A/lv
Publication of LV14230B publication Critical patent/LV14230B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

Meldonija [3-(2,2,2-trimetilhidrazīnij)propionāta dihidrāta] un tā farmaceitiskai lietošanai atļauto sāļu lietošana Parkinsona slimības profilaksei un ārstēšanai.
LVP-09-86A 2009-04-30 2009-04-30 Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai LV14230B (lv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-09-86A LV14230B (lv) 2009-04-30 2009-04-30 Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai
PCT/EP2010/002658 WO2010124873A1 (en) 2009-04-30 2010-04-30 3- (2, 2, 2, trimethylhydrazunium) propionate dihydrate (meldomium) for treating parkinson' s disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-09-86A LV14230B (lv) 2009-04-30 2009-04-30 Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai

Publications (2)

Publication Number Publication Date
LV14230A true LV14230A (lv) 2010-11-20
LV14230B LV14230B (lv) 2011-05-20

Family

ID=42651244

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-09-86A LV14230B (lv) 2009-04-30 2009-04-30 Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai

Country Status (2)

Country Link
LV (1) LV14230B (lv)
WO (1) WO2010124873A1 (lv)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2302011T3 (es) * 2003-08-04 2008-07-01 "JOINT STOCK COMPANY GRINDEKS" Sales de meldonio, metodo para su preparacion y composicion farmaceutica basado en las mismas.

Also Published As

Publication number Publication date
LV14230B (lv) 2011-05-20
WO2010124873A8 (en) 2011-03-31
WO2010124873A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
MX2020008616A (es) Rocio de fentanilo sublingual.
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX354210B (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
WO2008149382A8 (en) Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
WO2009017837A3 (en) Sublingual fentanyl spray
MX2010008921A (es) Derivados de oxazolidinona.
PL2371853T3 (pl) Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna, zastosowanie pochodnej insuliny lub jej farmaceutycznie dopuszczalnej soli oraz sposób leczenia
GEP20125624B (en) Pyridazine derivatives as smo inhibitors
MX2014000341A (es) Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
IN2012DN01233A (lv)
MX2009010407A (es) Derivados fluorados de deferiprona.
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
MX2011011109A (es) Formulaciones orales de bendamustina.
MX2013000694A (es) Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
ZA201007391B (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
IL210386A (en) Indole history, their medicinal preparations, and their use in the preparation of drugs for the treatment or prevention of neurodegenerative diseases
NZ602807A (en) 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor
UA109793C2 (uk) Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс)